Find and Pitch Jounalists, Get Your Story Covered

Tags: Software & Services Software Platforms IT Automation Apple cell biology, Craniofacial, developmental biology, DNA repair, genetics, oxidative stress

	Profile	Recent Articles on Subject
1	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	2024 PharmaVoice 100s: Clinical Trial Pros - 12 days ago 3 FDA approval dates to watch in the year’s final push - 2 months ago Autobahn’s road to a breakthrough depression treatment is paved with high-profile investors - 3 months ago To overcome barriers, cell and gene therapies need outside support - 4 months ago The hunt for the brain’s biomarkers - 5 months ago FDA’s platform designation aims to ease R&D pain points - 5 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 6 months ago As AI proliferates in pharma, regulators look to catch up in clinical trials - 7 months ago Black Diamond looks to outwit cancer mutations - 8 months ago For Moderna, COVID vaccines were a ‘proof of concept’ — now comes the big test - 9 months ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	2024 PharmaVoice 100s: Rare Disease Warriors - 14 days ago Is anyone taking the world’s priciest drugs? - 2 months ago Neuro drugs are still faltering, despite rising investment - 4 months ago Up-and-comers look for an edge in the bustling ADC field - 5 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 5 months ago Where competition is heating up in pharma - 6 months ago After Vyvanse patent loss, Takeda’s neuroscience division looks to enter a new era - 6 months ago Neurvati touts fresh, ‘synergistic’ investment model in neuroscience R&D - 8 months ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - 10 months ago PharmaVoice 100s: Clinical trial gurus - about 1 year ago 3 recent FDA adcomm rejections — and why they matter - about 1 year ago
3	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: U.K. charities give $36 million to start new drugs for childhood tumors - 2 months ago
4	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 3 months ago Key Market Trends for the Current Specialty Drug Pipeline - about 1 year ago
5	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Cardiovascular startup raises $260 million led by ex-Moderna execs’ new VC fund - 4 months ago
6	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	FDA finalizes guidance on studying opioid use disorder treatments - 4 months ago
7	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	A biotech’s binary bet ends badly - 5 months ago
8	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Another ADC Developer Lands a Mega Round of Financing for Cancer Clinical Trials - 7 months ago
9	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	Testing drugs on mini-cancers in the lab may reveal best treatment - 7 months ago
10	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: When a cancer drug fails, oncologists often fly blind. A precision technique might light the way - 7 months ago

Journalists covering drug development